Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name PI Organization Sort descending Title Grant Number Initiative Program Official
Masters, Gregory A

Christiana Care Health Services, Inc.
United States

Delaware Christiana Care NCORP 3UG1CA189819-11S1 Vanessa A. White, M.P.H.
Bruner, Deborah Watkins

Nrg Oncology Foundation, Inc.
United States

NRG Oncology NCORP Research Base-BIQSFP 3UG1CA189867-11S2 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Blanke, Charles D.

Oregon Health & Science University
United States

SWOG NCORP Research Base 3UG1CA189974-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Panda, Satchidananda

Salk Institute For Biological Studies
United States

Impact of Time-Restricted Feeding in Reducing Cancer Risk Through Optimizing Mitochondria Function 5R01CA258221-05 RFA-CA-20-004 (R01 Clinical Trial Optional) Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Hundley, William Gregory

Wake Forest University Health Sciences
United States

Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment 5R33CA226960-05 Eileen Dimond, R.N., M.S.
Rogers, Laura Q

University Of Alabama At Birmingham
United States

Role of gut microbe composition in psychosocial symptom response to exercise training in breast cancer survivors 5R01CA235598-06 Gabriela Riscuta, M.D., CNS
Maclean, Paul S.

University Of Colorado Denver
United States

Novel dietary interventions for reducing obesity-associated breast cancer 5R01CA258766-05 Young Kim, Ph.D.
Clare, Susan E.

Northwestern University At Chicago
United States

Lipid-initiated epigenetic reprogramming of the breast to a neural phenotype 1R21CA288676-01A1
Wallace, Douglas C

Children'S Hosp Of Philadelphia
United States

Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA 5R01CA259635-04 Young Kim, Ph.D.
Naicker, Nivashnee

Centre/Aids Programme/Res/South Africa
United States

CAPRISA CASCADE Clinical Trials Network Clinical Research Site 5UG1CA284671-03 Maria Silvina Frech, Ph.D., M.S.